Phase II selection design trial of concurrent chemotherapy and cetuximab versus chemotherapy followed by cetuximab in advanced-stage non-small-cell lung cancer: Southwest Oncology Group study S0342.
暂无分享,去创建一个
Edward S. Kim | J. Crowley | R. Herbst | F. Hirsch | K. Kelly | D. Gandara | W. Franklin | K. Chansky | S. Dakhil | K. Albain | P. Mack | J. Atkins | M. Redman | F. Hirsch